Cohen Joshua B
- SEC CIK
- 0001898644
In the past year, 6 open-market sale filings worth $4.03M and no purchases.
Current role at each company
- AMLX Amylyx Pharmaceuticals, Inc.Co-Chief Executive Officeras of Sep 14, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.03M
- 6 filings
- Net
- −$4.03M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cohen Joshua B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 (view filing)4:00 PM ET | Sep 10 | 4 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −30.5K | $32.19 | −$980.5K | −0.8%3.61M after | 2 lots |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −29.3K | $14.48 | −$424.0K | −0.9%3.33M after | |
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −15.5K | $14.68 | −$227.5K | −0.5%3.36M after | |
| Jan 20, 2026 (view filing) | Jan 15-16 | 5 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −138.2K | $13.59 | −$1.88M | −3.9%3.38M after | 2 lots |
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −7.71K | $11.09 | −$85.6K | −0.2%3.32M after | |
| Oct 2, 2025 (view filing) | Sep 30 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −29.9K | $14.34 | −$429.4K | −0.9%3.33M after | 2 lots |
| Apr 2, 2025 (view filing) | Mar 31 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −21.5K | $3.47 | −$74.6K | −0.6%3.36M after | |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −4.59K | $3.17 | −$14.6K | −0.1%3.20M after | |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −11.9K | $3.47 | −$41.1K | −0.4%3.20M after | |
| Jan 8, 2025 (view filing) | Jan 6 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −7.47K | $4.05 | −$30.3K | −0.2%3.21M after | |
| Oct 2, 2024 (view filing) | Sep 30 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −18.6K | $3.20 | −$59.5K | −0.6%3.22M after | |
| Mar 7, 2024 (view filing) | Mar 5 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −4.13K | $18.73 | −$77.4K | −0.1%3.02M after | |
| Jan 11, 2024 (view filing) | Jan 9 | 2 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −5.84K | $16.33 | −$95.4K | −0.2%2.90M after | |
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Cohen Joshua BCo-Chief Executive Officer | SSale | −100.0K | $31.86 | −$3.19M | −3.5%2.79M after | 2 lots |
| Jan 10, 2023 (view filing) | Jan 6 | 4 days | Cohen Joshua BCo-Chief Executive Officer | SSale | +5.97K | $36.30 | +$216.6K | +0.2%2.89M after | 2 lots |